25 agosto 2014
A drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukemia and other cancers, scientists have found. In this study, the research team also showed the link between the RUNX family genes and the pathway of a rare human congenital disease called Fanconi anemia for the first time.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Iw32hP_j68E/140825084450.htm
